HUANG Xue-yuan, CHEN Bing-yu, ZHOU Ming, et al. Clinical Significance of Platelet Antibody Detection——Based on Study of 2 338 Case from10 Institutions in China[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(2): 113-117.
1 Curtis B R，Edwards J T，Hessner M J，et al. Blood group A and B antigens are strongly expressed on platelets of some individuals[J]. Blood，2000，96（4）：1574-1581. 2 Vassallo R R. Recognition and management of antibodies to human platelet antigens in platelet transfusion-refractory patients[J]. Immunohematology，2009，25（3）：119-124. 3 Kreuger A L，Mäkelburg A B U，Somers J A E，et al. HLA-matched platelet transfusions are effective only in refractory patients with positive HLA antibody screening[J]. Transfusion，2019，59（11）：3303-3307. 4 Thulstrup H. The influence of leukocyte and thrombocyte incompatibility on non-haemolytic transfusion reactions.I.A retrospective study[J]. Vox Sang，1971，21（3）：233-250. 5 Rebulla P. Refractoriness to platelet transfusion[J]. CurrOpin Hematol，2002，9（6）：516-520. 6 Pavenski K，Freedman J，Semple J W. HLA alloimmun-ization against platelet transfusions：pathophysiology，significance，prevention and management[J]. Tissue Antigens，2012，79（4）：237-245. 7 Ghevaert C，Campbell K，Walton J，et al. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia[J]. Transfusion，2007，47（5）：901-910. 8 Winkelhorst D，Kamphuis M M，deKloet L C，et al. Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia：a case series and review of the literature[J]. Transfusion，2016，56（5）：1230-1235. 9 Mueller-Eckhardt C，Kiefel V，Grubert A，et al. 348 cases of suspected neonatal alloimmune thrombocytopenia[J]. Lancet，1989，1（8634）：363-366. 10 Winkelhorst D，Oepkes D，Lopriore E. Fetal and neonatal alloimmune thrombocytopenia：evidence based antenatal and postnatal management strategies[J]. Expert Rev Hematol，2017，10（8）：729-737. 11 Kiefel V，Konig C，Kroll H，et al. Platelet alloanti-bodies in transfused patients[J]. Transfusion，2001，41（6）：766-770. 12 Abraham A S，Chacko M P，Fouzia N A，et al. Antibodies to human platelet antigens form a significant proportion of platelet antibodies detected in Indian patients with refractoriness to platelet transfusions[J]. Transfus Med，2018，28（5）：392-397. 13 Vassallo R R，Fung M，Rebulla P，et al. Utility of cross-matched platelet transfusions in patients with hypoproliferativethrombocytopenia：a systematic review[J]. Transfusion，2014，54（4）：1180-1191. 14 Husebekk A. Fetal/Neonatal Alloimmune Thrombo-cytopenia （Fnait） [J]. Vox Sanguinis，2011，101：1-1. 15 Peterson J A，McFarland J G，Curtis B R，et al. Neo-natal alloimmune thrombocytopenia：pathogenesis，diagnosis and management[J]. Br J Haematol，2013，161（1）：3-14. 16 Sachs U J. Fetal/neonatal alloimmune thrombocyto-penia[J]. Thromb Res，2013，131（Suppl 1）：S42-S46. 17 Uhrynowska M，Niznikowska-Marks M，Zupańska B. Neonatal and maternal thrombocytopenia：incidence and immune background[J]. Eur J Haematol，2000，64（1）：42-46. 18 陈仁彪，包于勤，刘达庄，等. 血小板血型抗体在母婴免疫反应中的研究[J]. 上海免疫学杂志，1997，17（6）：362-364. 19 Nielsen H S，Witvliet M D，Steffensen R，et al. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth[J]. J Reprod Immunol，2010，87（1/2）：67-73. 20 谢仁伟，王明泉，李丽群，等. 孕晚期孕妇2038例血小板抗体筛查分析[J]. 福建医药杂志，2016，38（2）：98-99. 21 侯明，秦平. 成人原发免疫性血小板减少症诊治的中国专家共识（2016 版）解读[J]. 临床血液学杂志，2016，29（4）：523-527.
